Selank (10mg) protocols focus on this synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, studied for its potential anxiolytic (anti-anxiety), nootropic, and neuroregulatory effects. It is believed to support mood stability, stress resilience, and cognitive performance through modulation of GABAergic and neurotrophic pathways. This guide outlines a subcutaneous or intranasal administration approach optimized for the 10 mg vial format.
Concise summary of the administration regimen.
Suggested approach for the 10 mg vial format.
Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory peptide. It is designed to influence the central nervous system by modulating the expression of neurotransmitters involved in stress and anxiety regulation.
Research suggests Selank may enhance GABAergic signaling, which is associated with calming effects on neural activity. It may also influence serotonin and dopamine balance, contributing to mood stability and cognitive performance. Additionally, Selank has been studied for its potential to regulate brain-derived neurotrophic factor (BDNF), which is involved in learning, memory, and neuroplasticity. Unlike traditional anxiolytics, it does not appear to cause sedation or dependency in research settings.
Observations based on preclinical and clinical research literature.
Potential Benefits:
Possible Side Effects: